H Ballentine Carter

Professor

1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer

Rowe, S. P., Gage, K. L., Faraj, S. F., Macura, K. J., Cornish, T. C., Gonzalez-Roibon, N., Guner, G., Munari, E., Partin, A. W., Pavlovich, C. P., Han, M., Carter, H. B., Bivalacqua, T. J., Blackford, A., Holt, D., Dannals, R. F., Netto, G. J., Lodge, M. A., Mease, R. C., Pomper, M. G. & 1 others, Cho, S. Y., Jul 1 2015, In : Journal of Nuclear Medicine. 56, 7, p. 1003-1010 8 p.

Research output: Contribution to journalArticle

A Bayesian hierarchical model for prediction of latent health states from multiple data sources with application to active surveillance of prostate cancer

Coley, R. Y., Fisher, A. J., Mamawala, M., Carter, H. B., Pienta, K. & Zeger, S., Jun 1 2017, In : Biometrics. 73, 2, p. 625-634 10 p.

Research output: Contribution to journalArticle

Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program

Tosoian, J. J., Loeb, S., Kettermann, A., Landis, P., Elliot, D. J., Epstein, J. I., Partin, A. W., Carter, H. B. & Sokoll, L. J., Feb 1 2010, In : Journal of Urology. 183, 2, p. 534-538 5 p.

Research output: Contribution to journalArticle

A Clinicopathologic Study of Preoperative and Postoperative Findings with Minute Gleason 3+3=6 Cancer at Radical Prostatectomy

Osunkoya, A. O., Carter, H. B. & Epstein, J. I., Sep 1 2008, In : Urology. 72, 3, p. 638-640 3 p.

Research output: Contribution to journalArticle

A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer

Wu, Y., Yu, H., Zheng, S. L., Na, R., Mamawala, M., Landis, T., Wiley, K., Petkewicz, J., Shah, S., Shi, Z., Novakovic, K., McGuire, M., Brendler, C. B., Ding, Q., Helfand, B. T., Carter, H. B., Cooney, K. A., Isaacs, W. B. & Xu, J., Jun 1 2018, In : Prostate. 78, 8, p. 607-615 9 p.

Research output: Contribution to journalArticle

Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Tosoian, J. J., Mamawala, M., Epstein, J. I., Landis, P., Macura, K. J., Simopoulos, D. N., Carter, H. B. & Gorin, M. A., Jun 2020, In : European Urology. 77, 6, p. 675-682 8 p.

Research output: Contribution to journalArticle

Active surveillance program for prostate cancer: An update of the Johns Hopkins experience

Tosoian, J. J., Trock, B. J., Landis, P., Feng, Z., Epstein, J. I., Partin, A. W., Walsh, P. C. & Carter, H. B., Jun 1 2011, In : Journal of Clinical Oncology. 29, 16, p. 2185-2190 6 p.

Research output: Contribution to journalArticle

Active surveillance versus surgery for low risk prostate cancer: A clinical decision analysis

Liu, D., Lehmann, H. P., Frick, K. D. & Carter, H. B., Apr 1 2012, In : Journal of Urology. 187, 4, p. 1241-1246 6 p.

Research output: Contribution to journalArticle

Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions

Loeb, S., Zhou, Q., Siebert, U., Rochau, U., Jahn, B., Mühlberger, N., Carter, H. B., Lepor, H. & Braithwaite, R. S., 2017, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Adverse pathologic findings for men electing immediate radical prostatectomy defining a favorable intermediate-risk group

Patel, H. D., Tosoian, J. J., Carter, H. B. & Epstein, J. I., Jan 1 2018, In : JAMA oncology. 4, 1, p. 89-92 4 p.

Research output: Contribution to journalArticle

African american men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: Should active surveillance still be an option for them?

Sundi, D., Ross, A. E., Humphreys, E. B., Han, M., Partin, A. W., Carter, H. B. & Schaeffer, E. M., Aug 20 2013, In : Journal of Clinical Oncology. 31, 24, p. 2991-2997 7 p.

Research output: Contribution to journalArticle

Anatomical extent of lymph node dissection: Impact on men with clinically localized prostate cancer

Allaf, M. E., Palapattu, G. S., Trock, B. J., Carter, H. B. & Walsh, P. C., Nov 2004, In : Journal of Urology. 172, 5 I, p. 1840-1844 5 p.

Research output: Contribution to journalArticle

A novel quantitative multiplex tissue immunoblotting for biomarkers predicts a prostate cancer aggressive phenotype

Zhu, G., Liu, Z., Epstein, J. I., Davis, C., Christudass, C. S., Carter, H. B., Landis, P., Zhang, H., Chung, J. Y., Hewitt, S. M., Miller, M. C. & Veltri, R. W., Dec 2015, In : Cancer Epidemiology Biomarkers and Prevention. 24, 12, p. 1864-1872 9 p.

Research output: Contribution to journalArticle

A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

McKiernan, J., Donovan, M. J., Margolis, E., Partin, A. W., Carter, H. B., Brown, G., Torkler, P., Noerholm, M., Skog, J., Shore, N., Andriole, G., Thompson, I. & Carroll, P., Jan 1 2018, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Assessing risk: Does this patient have prostate cancer?

Carter, H. B., Apr 19 2006, In : Journal of the National Cancer Institute. 98, 8, p. 506-507 2 p.

Research output: Contribution to journalArticle

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer

Tosoian, J. J., Loeb, S., Feng, Z., Isharwal, S., Landis, P., Elliot, D. J., Veltri, R., Epstein, J. I., Partin, A. W., Carter, H. B., Trock, B. & Sokoll, L. J., Oct 1 2012, In : Journal of Urology. 188, 4, p. 1131-1136 6 p.

Research output: Contribution to journalArticle

Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States)

Hsieh, L. J., Carter, H. B., Landis, P. K., Tucker, K. L., Metter, E. J., Newschaffer, C. J. & Platz, E. A., Feb 1 2003, In : Urology. 61, 2, p. 297-301 5 p.

Research output: Contribution to journalArticle

Association of prostate cancer risk with insulin, glucose, and anthropometry in the baltimore longitudinal study of aging

Hubbard, J. S., Rohrmann, S., Landis, P. K., Metter, E. J., Muller, D. C., Andres, R., Carter, H. B. & Platz, E. A., Feb 2004, In : Urology. 63, 2, p. 253-258 6 p.

Research output: Contribution to journalArticle

Biopsy criteria for determining appropriateness for active surveillance in the modern era

Kryvenko, O. N., Carter, H. B., Trock, B. J. & Epstein, J. I., Apr 2014, In : Urology. 83, 4, p. 869-874 6 p.

Research output: Contribution to journalArticle

Bone mineral content and prostate cancer risk: Data from the Baltimore Longitudinal Study of Aging

Loeb, S., Carter, H. B., Schaeffer, E. M., Ling, S. M., Kettermann, A., Ferrucci, L. & Metter, E. J., Jul 1 2010, In : BJU International. 106, 1, p. 28-31 4 p.

Research output: Contribution to journalArticle

Calcium intake and prostate cancer risk in a long-term aging study: The Baltimore Longitudinal Study of Aging

Berndt, S. I., Carter, H. B., Landis, P. K., Tucker, K. L., Hsieh, L. J., Metter, E. J. & Platz, E. A., Dec 1 2002, In : Urology. 60, 6, p. 1118-1123 6 p.

Research output: Contribution to journalArticle

Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?

Carter, H. B., Landis, P., Wright, E. J., Parsons, J. K. & Metter, E. J., Jun 2005, In : Journal of Urology. 173, 6, p. 2040-2043 4 p.

Research output: Contribution to journalArticle

Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies

Nelson, W. G., Simons, J. W., Mikhak, B., Chang, J. F., DeMarzo, A. M., Carducci, M. A., Kim, M., Weber, C. E., Baccala, A. A., Goeman, M. A., Clift, S. M., Ando, D. G., Levitsky, H. I., Cohen, L. K., Sanda, M. G., Mulligan, R. C., Partin, A. W., Carter, H. B., Piantadosi, S. & Marshall, F. F., Nov 25 2000, In : Cancer Chemotherapy and Pharmacology. 46, SUPPL., p. S67-S72

Research output: Contribution to journalArticle

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Khan, M. A., Carter, H. B., Epstein, J. I., Miller, M. C., Landis, P., Walsh, P. W., Partin, A. W. & Veltri, R. W., Dec 2003, In : Journal of Urology. 170, 6 I, p. 2274-2278 5 p.

Research output: Contribution to journalArticle

Cell surface charge in predicting metastatic potential of aspirated cells from the dunning rat prostatic adenocarcinoma model

Carter, H. B. & Coffey, D. S., Jan 1 1988, In : Journal of Urology. 140, 1, p. 173-175 3 p.

Research output: Contribution to journalArticle

Change in Prostate Cancer Grade Over Time in Men Followed Expectantly for Stage T1c Disease

Sheridan, T. B., Carter, H. B., Wang, W., Landis, P. B. & Epstein, J. I., Mar 1 2008, In : Journal of Urology. 179, 3, p. 901-905 5 p.

Research output: Contribution to journalArticle

Characteristics and Experiences of Patients with Localized Prostate Cancer Who Left an Active Surveillance Program

Berger, Z. D., Yeh, J. C., Carter, H. B. & Pollack, C. E., Nov 22 2014, In : Patient. 7, 4, p. 427-436 10 p.

Research output: Contribution to journalArticle

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy

Partin, A. W., Piantadosi, S., Subong, E. N. P., Kelly, C. A., Hortopan, S., Chan, D. W., Wolfert, R. L., Rittenhouse, H. G. & Carter, H. B., Jan 1 1996, In : Prostate. 29, SUPPL. 7, p. 35-39 5 p.

Research output: Contribution to journalArticle

Clinical Evaluation of an Individualized Risk Prediction Tool for Men on Active Surveillance for Prostate Cancer

Huntley, J. H., Coley, R. Y., Carter, H. B., Radhakrishnan, A., Krakow, M. & Pollack, C., Nov 1 2018, In : Urology. 121, p. 118-124 7 p.

Research output: Contribution to journalArticle

Clinical evidence for and implications of the multistep development of prostate cancer

Ballentine Carter, H., Piantadosi, S. & Isaacs, J. T., Jan 1 1990, In : Journal of Urology. 143, 4, p. 742-746 5 p.

Research output: Contribution to journalArticle

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

Druskin, S. C., Tosoian, J. J., Young, A., Collica, S., Srivastava, A., Ghabili, K., Macura, K. J., Carter, H. B., Partin, A. W., Sokoll, L. J., Ross, A. E. & Pavlovich, C. P., Apr 2018, In : BJU International. 121, 4, p. 619-626 8 p.

Research output: Contribution to journalArticle

Comparative analysis of biopsy upgrading in four prostate cancer active surveillance cohorts

Inoue, L. Y. T., Lin, D. W., Newcomb, L. F., Leonardson, A. S., Ankerst, D., Gulati, R., Carter, H. B., Trock, B. J., Carroll, P. R., Cooperberg, M. R., Cowan, J. E., Klotz, L. H., Mamedov, A., Penson, D. F. & Etzioni, R., Jan 2 2018, In : Annals of internal medicine. 168, 1, p. 1-9 9 p.

Research output: Contribution to journalArticle

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection

Ross, K. S., Carter, H. B., Pearson, J. D. & Guess, H. A., Sep 20 2000, In : Journal of the American Medical Association. 284, 11, p. 1399-1405 7 p.

Research output: Contribution to journalArticle

Open Access

Complications after prostate biopsy: Data from SEER-Medicare

Loeb, S., Carter, H. B., Berndt, S. I., Ricker, W. & Schaeffer, E. M., Nov 1 2011, In : Journal of Urology. 186, 5, p. 1830-1834 5 p.

Research output: Contribution to journalArticle

Conditional probability of reclassification in an active surveillance program for prostate cancer

Alam, R., Carter, H. B., Landis, P., Epstein, J. I. & Mamawala, M., Jun 1 2015, In : Journal of Urology. 193, 6, p. 1950-1955 6 p.

Research output: Contribution to journalArticle

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy

Epstein, J. I., Pizov, G., Steinberg, G. D., Carter, H. B., Pitcock, R., Armas, O. A., Partin, A. & Walsh, P. C., Jan 1 1992, In : Journal of Urology. 148, 1, p. 87-91 5 p.

Research output: Contribution to journalArticle

Cost implications of PSA screening differ by age

Rao, K., Liang, S., Cardamone, M., Joshu, C. E., Marmen, K., Bhavsar, N., Nelson, W. G., Ballentine Carter, H., Albert, M. C., Platz, E. A. & Pollack, C. E., May 9 2018, In : BMC Urology. 18, 1, 38.

Research output: Contribution to journalArticle

Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage tlc disease

Epstein, J. I., Walsh, P. C., Carter, H. B., Monga, M., Ward, J. F., Piper, N. Y., Bishoff, J. T. & Kane, C. J., Jan 1 2001, In : Journal of Urology. 166, 5, p. 1688-1691 4 p.

Research output: Contribution to journalArticle

Delayed versus immediate surgical intervention and prostate cancer outcome

Warlick, C., Trock, B. J., Landis, P., Epstein, J. I. & Carter, H. B., Mar 1 2006, In : Journal of the National Cancer Institute. 98, 5, p. 355-357 3 p.

Research output: Contribution to journalArticle

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

Carter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J. & Metter, E. J., Nov 1 2006, In : Journal of the National Cancer Institute. 98, 21, p. 1521-1527 7 p.

Research output: Contribution to journalArticle